23410-20-0

Usage

Uses

Used in Pharmaceutical Industry:
2,5-dimethyl-4-aminoacetanilide serves as an intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new medications, particularly those with analgesic and fever-reducing properties, similar to its parent compound, acetanilide.
Used in Dye Industry:
2,5-dimethyl-4-aminoacetanilide also finds applications in the dye industry, where it is utilized in the production of different types of dyes. Its chemical properties make it suitable for creating a variety of colorants used in various applications.
Used in Organic Chemistry:
2,5-dimethyl-4-aminoacetanilide is relevant in the field of organic chemistry, where it can be employed in various chemical reactions and processes. Its amide and aromatic characteristics make it a versatile building block for synthesizing complex organic molecules.

Upstream product

• 3460-29-5 4-nitro-2,5-xylidine 
• 95-78-3 2,5-Dimethylaniline 
• 6954-69-4 N-(2,5-dimethyl-4-nitrophenyl)acetamide 
• 7803-57-8 hydrazine hydrate 
• 2050-44-4 N-(2,5-dimethylphenyl)acetamide 

Downstream Products

• 106423-99-8 2,2′,5,5′-tetramethyl-4,4′-azodiacetanilide 

Relevant academic research and scientific papers

Variable noninnocence of substituted azobis(phenylcyanamido)diruthenium complexes

The synthetic chemistry of substituted 4,4′-azobis(phenylcyanamide) ligands was investigated, and the complexes [{Ru(tpy)(bpy)}2( μ-L)][PF6]2, where L = 2,2′:5,5′-tetramethyl-4,4′-azobis(phenylcyanamido) (Me4adpc2-), 2,2′-dimethyl-4,4′-azobis(phenylcyanamido) (Me2adpc2-), unsubstituted (adpc2-), 3,3′-dichloro-4,4′-azobis(phenylcyanamido) (Cl2adpc2-), and 2,2′:5,5′-tetrachloro-4,4′-azobis(phenylcyanamido) (Cl4adpc2-), were prepared and characterized by cyclic voltammetry and vis-near-IR (NIR) and IR spectroelectrochemistry. The room temperature electron paramagnetic resonance spectrum of [{Ru(tpy)(bpy)}2( μ-Me4adpc)]3+ showed an organic radical signal and is consistent with an oxidation-state description [RuII, Me4adpc?-, RuII]3+, while that of [{Ru(tpy)(bpy)}2( μ-Cl2adpc)]3+ at 10 K showed a low-symmetry RuIII signal, which is consistent with the description [RuIII, Cl2adpc2-, RuII]3+. IR spectroelectrochemistry data suggest that [{Ru(tpy)(bpy)}2( μ-adpc)]3+ is delocalized and [{Ru(tpy)(bpy)}2( μ-Cl2adpc)]3+ and [{Ru(tpy)(bpy)}2( μ-Cl4adpc)]3+ are valence-trapped mixed-valence systems. A NIR absorption band that is unique to all [{Ru(tpy)(bpy)}2( μ-L)]3+ complexes is observed; however, its energy and intensity vary depending on the nature of the bridging ligand and, hence, the complexes oxidation-state description.